Skip to product information
1 of 1
Sold Out

Methodological Challenges in Biomedical HIV Prevention Trials

Methodological Challenges in Biomedical HIV Prevention Trials

Paperback

Regular price £64.70
Regular price Sale price £64.70

Join our rewards scheme and earn 195 reward points on this purchase!

Earn 195 points on this!

Sign in or Sign up!
View full details
  • Release Date: 13/05/2008
  • Barcode: 9780309114301
  • Imprint: National Academies Press
  • Publisher: National Academies Press
Methodological Challenges in Biomedical HIV Prevention Trials

Methodological Challenges in Biomedical HIV Prevention Trials

Collapsible content

DESCRIPTION

At the request of the Bill & Melinda Gates Foundation, Methodological Challenges in Biomedical HIV Prevention Trials addresses methodological challenges in late-stage nonvaccine biomedical HIV prevention trials with a specific focus on microbicide and pre-exposure prophylaxis trials.
The number of people infected with HIV or living with AIDS is increasing at unprecedented rates as various scientists, organizations, and institutions search for innovative solutions to combating and preventing the disease. At the request of the Bill & Melinda Gates Foundation, Methodological Challenges in Biomedical HIV Prevention Trials addresses methodological challenges in late-stage nonvaccine biomedical HIV prevention trials with a specific focus on microbicide and pre-exposure prophylaxis trials. This book recommends a number of ways to improve the design, monitoring, and analysis of late-stage clinical trials that evaluate nonvaccine biomedical interventions. The objectives include identifying a beneficial method of intervention, enhancing quantification of the impact, properly assessing the effects of using such an intervention, and reducing biases that can lead to false positive trial results. According to Methodological Challenges in Biomedical HIV Prevention Trials, the need to identify a range of effective, practical, and affordable preventive strategies is critical.Although a large number of promising new HIV prevention strategies and products are currently being tested in late-stage clinical trials, these trials face a myriad of methodological challenges that slow the pace of research and limit the ability to identify and fully evaluate effective biomedical interventions.

ADDITIONAL DETAILS

  • Contributor: Alicia R. Gable (Edited by), Stephen W. Lagakos (Edited by)
  • DELIVERY & RETURNS

    UK Delivery:

    • Free delivery on all orders of £10 or more.
    • £1.49 delivery fee on orders below £10.
    • UK orders are shipped via Royal Mail 2nd Class.

    International Delivery:

    • Flat rate delivery charges vary by country.

    Dispatch and Delivery Times:

    • All orders are shipped from our warehouse in Northampton, UK within 48 hours of receipt during working hours.
    • UK mainland orders typically arrive within 3-5 working days via Royal Mail 2nd Class.
    • International estimated delivery times:
    • Europe & Channel Islands: 7 to 10 working days
    • USA: 7 to 15 working days
    • Rest of the World: 9 to 21 working days

    View our full delivery infomation here.

    • OVER

      2 MILLION PRODUCTS

    • 60 MILLION CUSTOMERS

      ACROSS 190 COUNTRIES